{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:02:27Z","timestamp":1793638947809,"version":"4.5.1"},"reference-count":16,"publisher":"Baishideng Publishing Group Inc.","issue":"29","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2008]]},"DOI":"10.3748\/wjg.14.4697","type":"journal-article","created":{"date-parts":[[2008,8,14]],"date-time":"2008-08-14T02:29:49Z","timestamp":1218680989000},"page":"4697","source":"Crossref","is-referenced-by-count":41,"title":["Vanishing bile duct and Stevens-Johnson syndrome associated with ciprofloxacin treated with tacrolimus"],"prefix":"10.3748","volume":"14","author":[{"given":"Gokhan","family":"Okan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serpil","family":"Yaylaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onder","family":"Peker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabahattin","family":"Kaymakoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Saruc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Morelli MS, O'Brien FX. Stevens-Johnson Syndrome and cholestatic hepatitis. Dig Dis Sci 2001;46:2385-2388.","DOI":"10.1023\/A:1012351231143"},{"key":"ref2","unstructured":"Cac NN, Messingham MJ, Sniezek PJ, Walling HW. Stevens-Johnson syndrome induced by doxycycline. Cutis 2007;79:119-122."},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, Sidoroff A, Schneck J, Roujeau JC, Flahault A. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol 2008;128:35-44.","DOI":"10.1038\/sj.jid.5701033"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, Auquier A, Bastuji-Garin S, Correia O, Locati F. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600-1607.","DOI":"10.1056\/NEJM199512143332404"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Srivastava M, Perez-Atayde A, Jonas MM. Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndromes in a child. Gastroenterology 1998;115:743-746.","DOI":"10.1016\/S0016-5085(98)70154-4"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Hallgren J, Tengvall-Linder M, Persson M, Wahlgren CF. Stevens-Johnson syndrome associated with ciprofloxacin: a review of adverse cutaneous events reported in Sweden as associated with this drug. J Am Acad Dermatol 2003;49:S267-S269.","DOI":"10.1016\/S0190-9622(03)00478-X"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Garcia M, Mhanna MJ, Chung-Park MJ, Davis PH, Srivastava MD. Efficacy of early immunosuppressive therapy in a child with carbamazepine-associated vanishing bile duct and Stevens-Johnson syndromes. Dig Dis Sci 2002;47:177-182.","DOI":"10.1023\/A:1013296310944"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Pirmohamed M, Kitteringham NR, Breckenridge AM, Park BK. Detection of an autoantibody directed against human liver microsomal protein in a patient with carbamazepine hypersensitivity. Br J Clin Pharmacol 1992;33:183-186.","DOI":"10.1111\/j.1365-2125.1992.tb04022.x"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 2002;36:525-531.","DOI":"10.1053\/jhep.2002.36088"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Jakab SS, West AB, Meighan DM, Brown RS Jr, Hale WB. Mycophenolate mofetil for drug-induced vanishing bile duct syndrome. World J Gastroenterol 2007;13:6087-6089.","DOI":"10.3748\/wjg.v13.45.6087"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Caproni M, Torchia D, Schincaglia E, Volpi W, Frezzolini A, Schena D, Marzano A, Quaglino P, De Simone C, Parodi A. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome\/toxic epidermal necrolysis. Br J Dermatol 2006;155:722-728.","DOI":"10.1111\/j.1365-2133.2006.07398.x"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Chia FL, Leong KP. Severe cutaneous adverse reactions to drugs. Curr Opin Allergy Clin Immunol 2007;7:304-309.","DOI":"10.1097\/ACI.0b013e328216f54a"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Ingelman-Sundberg M. Pharmacogenomic biomarkers for prediction of severe adverse drug reactions. N Engl J Med 2008;358:637-639.","DOI":"10.1056\/NEJMe0708842"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Chung WH, Hung SI, Chen YT. Human leukocyte antigens and drug hypersensitivity. Curr Opin Allergy Clin Immunol 2007;7:317-323.","DOI":"10.1097\/ACI.0b013e3282370c5f"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Man CB, Kwan P, Baum L, Yu E, Lau KM, Cheng AS, Ng MH. Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia 2007;48:1015-1018.","DOI":"10.1111\/j.1528-1167.2007.01022.x"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Mallal S, Phillips E, Carosi G, Molina JM, Workman C, Tomazic J, Jagel-Guedes E, Rugina S, Kozyrev O, Cid JF. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 2008;358:568-579.","DOI":"10.1056\/NEJMoa0706135"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v14\/i29\/4697.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T10:10:22Z","timestamp":1557742222000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v14\/i29\/4697.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":16,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.14.4697","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]}}}